A detailed history of New York State Common Retirement Fund transactions in Biogen Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 94,745 shares of BIIB stock, worth $15 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
94,745
Previous 111,252 14.84%
Holding current value
$15 Million
Previous $25.8 Million 28.79%
% of portfolio
0.02%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$189.07 - $236.8 $3.12 Million - $3.91 Million
-16,507 Reduced 14.84%
94,745 $18.4 Million
Q2 2024

Jul 31, 2024

BUY
$190.52 - $236.72 $395,710 - $491,667
2,077 Added 1.9%
111,252 $25.8 Million
Q1 2024

May 07, 2024

SELL
$212.02 - $267.71 $2.97 Million - $3.76 Million
-14,028 Reduced 11.39%
109,175 $23.5 Million
Q4 2023

Feb 01, 2024

SELL
$222.59 - $267.94 $2.84 Million - $3.42 Million
-12,777 Reduced 9.4%
123,203 $31.9 Million
Q3 2023

Nov 07, 2023

SELL
$253.3 - $285.89 $5.26 Million - $5.94 Million
-20,760 Reduced 13.24%
135,980 $34.9 Million
Q2 2023

Aug 07, 2023

SELL
$275.25 - $318.06 $304,151 - $351,456
-1,105 Reduced 0.7%
156,740 $44.6 Million
Q1 2023

May 02, 2023

SELL
$256.56 - $292.34 $1.59 Million - $1.81 Million
-6,193 Reduced 3.78%
157,845 $43.9 Million
Q4 2022

Jan 30, 2023

SELL
$252.44 - $306.72 $44,429 - $53,982
-176 Reduced 0.11%
164,038 $45.4 Million
Q3 2022

Nov 08, 2022

SELL
$194.69 - $268.46 $809,910 - $1.12 Million
-4,160 Reduced 2.47%
164,214 $43.8 Million
Q2 2022

Aug 04, 2022

SELL
$187.54 - $223.02 $20.4 Million - $24.2 Million
-108,637 Reduced 39.22%
168,374 $34.3 Million
Q1 2022

May 05, 2022

BUY
$193.77 - $244.14 $964,974 - $1.22 Million
4,980 Added 1.83%
277,011 $58.3 Million
Q4 2021

Feb 02, 2022

SELL
$223.92 - $287.77 $1.27 Million - $1.64 Million
-5,682 Reduced 2.05%
272,031 $65.3 Million
Q3 2021

Nov 02, 2021

SELL
$282.99 - $369.05 $3.13 Million - $4.09 Million
-11,076 Reduced 3.84%
277,713 $78.6 Million
Q2 2021

Aug 02, 2021

SELL
$259.0 - $414.71 $831,649 - $1.33 Million
-3,211 Reduced 1.1%
288,789 $100 Million
Q1 2021

May 11, 2021

SELL
$242.95 - $284.63 $5.37 Million - $6.29 Million
-22,084 Reduced 7.03%
292,000 $81.7 Million
Q4 2020

Feb 08, 2021

SELL
$236.26 - $355.63 $6.36 Million - $9.57 Million
-26,904 Reduced 7.89%
314,084 $76.9 Million
Q3 2020

Nov 05, 2020

SELL
$264.77 - $305.71 $4.65 Million - $5.37 Million
-17,561 Reduced 4.9%
340,988 $96.7 Million
Q2 2020

Aug 07, 2020

SELL
$258.66 - $342.55 $13.2 Million - $17.4 Million
-50,848 Reduced 12.42%
358,549 $95.9 Million
Q1 2020

May 06, 2020

SELL
$268.85 - $341.04 $2.88 Million - $3.65 Million
-10,713 Reduced 2.55%
409,397 $130 Million
Q4 2019

Feb 05, 2020

SELL
$220.06 - $304.07 $4.53 Million - $6.26 Million
-20,595 Reduced 4.67%
420,110 $125 Million
Q3 2019

Nov 07, 2019

SELL
$217.44 - $243.88 $5 Million - $5.61 Million
-23,009 Reduced 4.96%
440,705 $103 Million
Q2 2019

Aug 09, 2019

SELL
$219.29 - $241.72 $2.3 Million - $2.54 Million
-10,511 Reduced 2.22%
463,714 $108 Million
Q1 2019

May 08, 2019

SELL
$216.71 - $338.96 $2.14 Million - $3.34 Million
-9,855 Reduced 2.04%
474,225 $112 Million
Q4 2018

Feb 08, 2019

SELL
$278.5 - $352.75 $7.97 Million - $10.1 Million
-28,600 Reduced 5.58%
484,080 $146 Million
Q3 2018

Nov 07, 2018

SELL
$293.51 - $383.83 $6.57 Million - $8.59 Million
-22,388 Reduced 4.18%
512,680 $181 Million
Q2 2018

Aug 10, 2018

SELL
$257.52 - $306.91 $8.59 Million - $10.2 Million
-33,350 Reduced 5.87%
535,068 $155 Million
Q1 2018

May 10, 2018

SELL
$260.13 - $367.91 $949,474 - $1.34 Million
-3,650 Reduced 0.64%
568,418 $156 Million
Q4 2017

Feb 13, 2018

BUY
$307.64 - $344.58 $123,056 - $137,832
400 Added 0.07%
572,068 $182 Million
Q3 2017

Nov 06, 2017

SELL
$281.15 - $329.69 $2.87 Million - $3.36 Million
-10,200 Reduced 1.75%
571,668 $179 Million
Q2 2017

Aug 11, 2017

BUY
N/A
581,868
581,868 $158 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.